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These are important topics for therapeutic strategies 
because pidemiologically targeted rug therapies to de- 
mographic profiles such as race may be attractive for 
agencies disbursing limited health care dollars. However, as 
the author of this chapter points out, genetic expression of 
disease and efficacy of drugs may not be the same in people 
of the same identifiable phenotypic marker such as skin 
color. These chapters are excellent additions and provide 
information that is often difficult to find in comprehensive 
textbooks of pharmacology. Two appendixed tables also 
provide easy reference for changes in pharmacokinetics of 
common cardiovascular d ugs in the elderly and common 
adverse interactions involving cardiovascular d ugs. 
In spite of the comprehensive nature of the book, there 
are no sections related to therapeutic interventions for 
venous and lymphatic disease. This may reflect he lack of 
availability of efficacious pharmacologic therapy for these 
diseases in the United States. 
In summary, this is an up-to-date text of the current 
strategies for treatment of common cardiovascular disor- 
ders. The book should be a valuable reference not only for 
the cardiologists and internists, but also for family practi- 
tioners and surgeons who deal with aspects of cardiovas- 
cular medicine in their practice. Basic scientists will find the 
text useful for understanding clinical problems and strate- 
gies for therapeutic interventions for cardiovascular dis- 
eases. 
Vi~inia ~Iiller, PbD 
Dustan A. Barber, RPb, PbD 
Mayo Clinic 
Rochester, Minn. 
Reperfusion injuries and clinical capillary 
leak syndrome 
B. A. Zikria, et al., Armonk, N.Y., 1994, Futura 
Publishing Co., 617 pages, $85. 
The authors propose a clinical capillary leak syndrome 
as the unifying hypothesis between ischemia-reperfusion 
scenarios. This is highlighted in the chapters authored by 
Dr. Zikria. Subsections include endothelium, basic prin- 
ciples, clinical reperfusion syndromes, transplanta- 
tion, multiple organ failure (MOF), and finally future 
horizons. 
The author notes difficulty in finding the term "clinical 
capillary leak syndrome" in the medical literature and hopes 
to broaden its usage; apparently the term has been used to 
describe a clinical picture similar to MOF in patients 
undergoing chemotherapy. A "biophysical" (as opposed to 
biochemical) approach to these syndromes is proposed, 
along with therapy derived from this approach. They have 
used large molecules of starch in an effort to "seal" or 
"plug" the leaky sites. The authors' definition of clinical 
capillary leak syndrome (p. 472) is unfortunate: "Clinical 
capillary leak syndrome is often observed in patients who, 
following shock. . ,  demonstrate a state of generalized 
leaky capillaries." Absence of objective criteria is empha- 
sized by use of nonquantitative modifiers uch as general- 
ized, decreased, and possible to characterize the syndrome 
beyond kidney and lung failure. 
A distinguished group of collaborators contribute 
detailed information ranging from anatomic consider- 
ations to emerging molecular models. The initial sections 
review information ot acquired uring the usual course of 
medical and surgical training. These contributions are 
extensively referenced. A problem hindering the study of 
ischemia-reperfusion injury has been the relatively slow 
translation of research findings to clinical practice. In 
contrast, with transplantation, intervention before the 
ischemic insult has produced major improvements in organ 
preservation. MOF, like ischemia-reperfusion, is treated 
after recognition of the physiologic derangement. Accord- 
ing to Dr. Zikria, the promise of immunotherapy is largely 
unfulfilled despite rapid identification of specific agents and 
recombinant antisera. The ineffectiveness of single-agent 
interventions suggests a need for multiagent rials, or a 
completely different approach. 
The last chapter describes the use of Hespan and 
Pentastarch in the clinical capillary leak syndromes. Al- 
though there are encouraging experimental data to support 
further investigation, the authors have only begun to fulfill 
the promise of this therapy. If "capillary plugging" were 
capable of functional tissue preservation despite ndothelial 
injury, further investigation of this approach would be 
exciting. Does "plugging" improve cellular oxygen utiliza- 
tion? Does controlling edema alter outcome of ischemia- 
reperfusion injury or MOF? 
The physical presentation of this book is marred by an 
insertion sheet correcting adiagram (p. 99) and separation 
of the back end paper. Although the latter may be 
attributed to postal mishandling, the former was a major 
annoyance. In summary, the text offers detailed and topical 
reviews and may serve as a good starting point for 
developing a knowledge base in fluid management, mem- 
brane permeability, and clinical reperfusion syndromes. 
The suggestion and promise of "pore plugging" may 
represent a fertile field for further investigations. For these 
selected groups purchase of this text may provide a valuable 
summary of knowledge in this field. 
Frank Padberg, Jr., MD 
VA Medical Center 
East Orange, N.J. 
Aneurysm surgery 
I. Faris and B. Buxton, Edinburgh, 1995, Churchill 
Livingstone, 282 pages, $185. 
Aneurysm surgery is central to the practice of vascular 
surgery, and this book is a welcome addition to  the 
ever-growing library of vascular literature. Two primary 
contributors have illustrated the major procedures per- 
formed to treat arterial aneurysms. The subject content 
begins with perioperative management and progresses 
rapidly to thoracic, thoracoabdominal, bdominal, lower 
extremity, renal, and visceral aneurysms. Thoughtful dis- 
cussion of inflammatory, infected, and false aneurysms, as 
